Icosapent-ethyl ester

icosapent ethyl · Amarin Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Icosapent-ethyl ester, covering 2024-12-13 to 2024-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease. [NA]